WHO ICTRP trial
Exploring the molecular mechanism of PIAS1 regulating ferroptosis by activating…
ChiCTR2600117268 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2600117268 |
|---|---|
| Public title | Exploring the molecular mechanism of PIAS1 regulating ferroptosis by activating the TAL1/SLC7A11 axis and affecting the occurrence and development of non-small cell lung cancer based on SUMOylation modification |
| Scientific title | Exploring the molecular mechanism of PIAS1 regulating ferroptosis by activating the TAL1/SLC7A11 axis and affecting the occurrence and development of non-small cell lung cancer based on SUMOylation modification |
| Primary sponsor | Ningbo Medical Centre Lihuili Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 0 |
| Countries | China |
| Conditions | Non-small cell lung cancer |
| Interventions | Group of non-small cell lung cancer:None |
| Registration date | Jan 21, 2026 |
| Target size | Group of non-small cell lung cancer:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: